LONDON & NEW YORK, June 23, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the successful ...

Exelixis, Inc. (Nasdaq: EXEL) today announced positive topline results from the STELLAR-303 phase 3 pivotal trial in which zanzalintinib in combination with ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial.

In this work, we investigate the effect of the alkyl chain length of the nitrogenous cation on the ionicity of formic acid–trialkylamine mixtures at 298.15 K, and the nature of the formed bonds using ...

Organosulfates (OSs) are ubiquitous in atmospheric particulate matter and serve as key tracers of secondary organic aerosols. Traditionally, OSs have been primarily linked to the particle phase with ...